Previous 10 | Next 10 |
Image source: The Motley Fool. Staar Surgical Co (NASDAQ: STAA) Q3 2019 Earnings Call Oct 30, 2019 , 4:30 p.m. ET Operator Continue reading
STAAR Surgical Company (STAA) Q3 2019 Earnings Conference Call October 30, 2019 16:30 ET Company Participants Brian Moore - Senior Director, Investor, Media Relations and Corporate Development Caren Mason - President and Chief Executive Officer Deborah Andrews - Chief Financial O...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended September 27, 2019. Third Quarter 2019 Overview Net Sales of $39.1...
Ophthalmologist Jorn S. Jorgensen, CEO and Founder of EuroEyes, Implanted EVO ICLs in His Son, Jannik Jorgensen STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended September 27, 2019 on Wednesday, October 30, 2019 ...
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 120 weeks of public selections as part of this ongoing live forward-testing. In...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing the EVO ICL Clinical Program which will be presented by Ophthalmic Surgeons to Ophthalmic Surgeons at its invitation only...
World Class Eye Institute Positions ICL as Primary and Premium Vision Correction Procedure STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it has entered a str...
STAAR Surgical (NASDAQ: STAA ) announces that the FDA in a letter dated August 23, 2019, has determined that the company has provided sufficient data to support initiation of a human clinical study in the U.S. of the EVO/EVO+ VISIAN Implantable Collamer Lens for Myopia, and EVO/EVO+ V...
EVO/EVO+ VISIAN® Implantable Collamer® Lens for Myopia, and EVO/EVO+ VISIAN® Toric Implantable Collamer® Lens for Myopia with Astigmatism Additional Study Recommendations and Considerations to be Addressed STAAR Surgical Company (NASDAQ: STAA), a leading devel...
News, Short Squeeze, Breakout and More Instantly...
STAAR Surgical Company Company Name:
STAA Stock Symbol:
NASDAQ Market:
STAAR Surgical Company Website:
2024-07-14 17:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with Patrick F. Will...
2024-05-24 07:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...